P. Błoński

发表

Long-term efficacy of neoadjuvant-adjuvant targeted therapy in borderline resectable stage IIIB-D and IV melanoma.

A. Szumera-Ciećkiewicz, P. Rogala, A. Borkowska, 2024, Cancer.

Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma

A. Czarnecka, A. Szumera-Ciećkiewicz, K. Ostaszewski, 2024, Biomedicines.

Establishing biomarkers for soft tissue sarcomas

Paulina Chmiel, P. Rutkowski, A. Czarnecka, 2024, Expert review of anticancer therapy.

Preoperative-postoperative immunotherapy as treatment of borderline resectable and oligoprogressive stage III B-D and IV melanoma.

A. Szumera-Ciećkiewicz, P. Rogala, M. Dudzisz-Śledź, 2024, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.